Feb. 23 Quick Takes: BGI raises $300M, plus a $230M C round for Clover, Day One, Waksal’s Graviton, Asalyxa
BGI Genomics Co. Ltd. (SZSE:300676) raised RMB2 billion ($309 million) through the sale of 13.8 million shares at RMB145 in a private placement. Huatai Securities Co. Ltd. purchased 8.3 million shares; also buying shares were China Merchants Securities, Central SOE Poverty Area Industrial Investment Fund and Tianjin Liren Asset Management Partnership.
Clover raises $230 million series C
Clover Biopharmaceuticals Inc. $230 million in an oversubscribed series C round co-led by GL Ventures and Temasek. New investors Oceanpine Capital and OrbiMed Advisors and existing investor Delos Capital participated in the round, which will help the company advance its pipeline of protein-based vaccines and biologics including its COVID-19 vaccine SCB-2019 slated to start a Phase II/III trial this half...